AVATROMBOPAG | AVATROMBOPAG | ATC B02BX08
BLOOD THROMBOPOIETIN RECEPTOR AGONIST (TPO) TREATMENT OF THROMBOCYTOPENIA INCREASED PRODUCTION OF PLATELETS | ORAL | Cmax 255.6 NANOMOLAR Tmax 5.5 HOUR VD 180 LITER PPB 96 PERCENT Cl 6.9 LITER / HOUR HT 19 HOUR SOLUBILITY PRACTICALLY INSOLUBLE AT PH 1 TO 11 | THROMBOPOIETIN RECEPTOR | Thrombopoietin receptor UNIPROT P40238 MPL more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |